Description
Retatrutide is a synthetic peptide research compound built as a triple agonist at the GIP, GLP-1, and glucagon receptors. It is used to study how three metabolic pathways respond when engaged together.
Non-clinical studies in cell and animal models have examined glucose regulation, energy output, lipid processing, and integrated three-receptor signaling. Its multi-target profile makes it valuable for comparative metabolic research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.








Reviews
There are no reviews yet.